Oliver Klein
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
-
- Diabetes Management and Research
- Diabetes Treatment and Management
Papers in
- Oncology 36
- Cancer Immunotherapy and Biomarkers 25
- CAR-T cell therapy research 11
-
- Diabetes Management and Research 16
- Diabetes Treatment and Management 12
- Co-authors
- Jonathan CebonGeorgina V. LongAlexander M. MenziesMatteo S. CarlinoTim HeiseLeszek NosekRyan J. SullivanAlexander Guminski
- Journals
- Journal of Clinical Oncology (10 papers)Diabetes Obesity and Metabolism (7 papers)Annals of Oncology (4 papers)Diabetes (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Oliver Klein
60 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.6k
- Endocrinology, Diabetes and Metabolism 582
- Immunology 513
- Genetics 162
- Surgery 569
Countries citing papers authored by Oliver Klein
This map shows the geographic impact of Oliver Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Klein more than expected).
Fields of papers citing papers by Oliver Klein
This network shows the impact of papers produced by Oliver Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Klein. The network helps show where Oliver Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | A gut microbial signature for combination immune checkpoint blockade across cancer types Hit paper breakdown → | 2024 | 67 |
| 3 | 2024 | 2 | |
| 4 | 2022 | 10 | |
| 5 | 2022 | 20 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 15 | |
| 9 | 2020 | 116 | |
| 10 | 2019 | 20 | |
| 11 | 2019 | 6 | |
| 12 | 2018 | 32 | |
| 13 | 2017 | 81 | |
| 14 | Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab Hit paper breakdown → | 2016 | 604 |
| 15 | 2016 | 3 | |
| 16 | 2016 | 92 | |
| 17 | 2015 | 32 | |
| 18 | 2014 | 56 | |
| 19 | 2012 | 89 | |
| 20 | 1998 | 27 |
About Oliver Klein
Oliver Klein is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Immunology, Surgery and Gastroenterology, having authored 64 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Diabetes Management and Research (16 papers), Diabetes Treatment and Management (12 papers), Pancreatic function and diabetes (12 papers), CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (10 papers), Melanoma and MAPK Pathways (7 papers) and Diabetes and associated disorders (5 papers). The work is most often cited by research in Oncology (1.6k citations), Endocrinology, Diabetes and Metabolism (582 citations), Immunology (513 citations), Genetics (162 citations) and Surgery (569 citations). Oliver Klein has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Jonathan Cebon, Georgina V. Long, Alexander M. Menzies, Matteo S. Carlino, Tim Heise, Leszek Nosek, Ryan J. Sullivan, Alexander Guminski, Richard Kefford and Victoria Atkinson. Their work appears in journals such as Journal of Clinical Oncology, Diabetes Obesity and Metabolism, Annals of Oncology, Diabetes and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.